Details of the Optogenetic System
| General Information of This Optogenetic System (OS) | ||||||
|---|---|---|---|---|---|---|
| OS ID | 
					 OS00626 
				 | 
			|||||
| OS Name | 
						 Optogenetic multiple sclerosis mechanism researching system 3
							(OptoMSMR 3) 
					 | 
					[1] | ||||
| 
						Photoreceptor (PR) | 
					
					
					
  | 
				|||||
| Complementary Protein | Cryptochrome-interacting basic-helix-loop-helix 1 (CIB1/CIBN) | |||||
| Cofactor | Flavin adenine dinucleotide (FAD) | |||||
| Controlled Protein | Fusion protein | Heterogeneous ribonucleoprotein A1 | ||||
| OS Application Information (1) | ||||||
|---|---|---|---|---|---|---|
| Mechanism of Action | CRY2 cluster | [ 1] | ||||
| Controlled Signal Pathway | hnRNPA1 self-association | |||||
| Effect | Sensor | |||||
| Application | Mechanism analysis of A1 self-association dynamics and protein mislocalization in Multiple sclerosis | |||||
| Note | Mutations within the C-terminal prion-like domain of RNA binding proteins alter protein-protein interactions will lead to mislocalization and aggregate formation | |||||
| Light Information | Activation Wavelength | 465 nm | ||||
| Process | Reversible | |||||
| Deactivation Wavelength | Dark | |||||
| Activation Time | 120 min | |||||
| Deactivation Time | 60 min | |||||
| Light Intensity | 10000 lux | |||||
| Expression Information | Expression Method | Transfection | ||||
| Cell Lines | HEK293T cells | |||||